{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:16:31Z","timestamp":1790662591601,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4511,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1046\/j.1523-1755.2003.00099.x","type":"journal-article","created":{"date-parts":[[2003,7,8]],"date-time":"2003-07-08T11:46:46Z","timestamp":1057664806000},"page":"572-578","source":"Crossref","is-referenced-by-count":74,"title":["Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin"],"prefix":"10.1016","volume":"64","author":[{"given":"G\u00fcnter","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Meusburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Radacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Garimorth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Neyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1989.18","article-title":"The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin","volume":"35","author":"Eschbach","year":"1989","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0015","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/ndt\/16.suppl_7.25","article-title":"Hyporesponsiveness to recombinant human erythropoietin","volume":"16","author":"Drueke","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V80.7.1639.1639","article-title":"Progress in understanding the pathogenesis of the anemia of chronic disease","volume":"80","author":"Means","year":"1992","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0025","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69012.x","article-title":"Iron and the anemia of chronic disease","volume":"69","author":"Weiss","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of anemia in end stage renal disease with recombinant human erythropoietin","volume":"316","author":"Eschbach","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0035","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69049.x","article-title":"Erythropoietin and iron","volume":"69","author":"Kaltwasser","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bmj.304.6821.225","article-title":"Detection of functional iron deficiency during erythropoietin treatment","volume":"304","author":"MacDougall","year":"1992","journal-title":"Br Med J"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/oxfordjournals.ndt.a027248","article-title":"Consensus statement. How to diagnose and correct iron deficiency during rhEpo therapy. A consensus report","volume":"11","author":"H\u00f6rl","year":"1996","journal-title":"Neprol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0050","series-title":"Iron Metabolism in Health and Disease","first-page":"353","article-title":"Iron in infection, immunity, inflammation and neoplasia,","author":"Brock","year":"1994"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0055","first-page":"605","article-title":"Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1","volume":"20","author":"Weiss","year":"1992","journal-title":"Exp Hematol"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0060","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69125.x","article-title":"Iron and infection","volume":"69","author":"Patruta","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0065","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3201\/eid0503.990305","article-title":"Iron loading and disease surveillance","volume":"5","author":"Weinberg","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1096\/fasebj.9.2.7540156","article-title":"Free radicals and phagocytic cells","volume":"9","author":"Rosen","year":"1995","journal-title":"FASEB J"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol: Modification of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.86.3.803","article-title":"High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men","volume":"86","author":"Salonen","year":"1992","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.CIR.89.1.102","article-title":"Low iron-binding capacity as a risk factor for myocardial infarction","volume":"89","author":"Magnusson","year":"1994","journal-title":"Circulation"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/oxfordjournals.aje.a117060","article-title":"Iron status and coronary heart disease: Negative findings from the NHANES I epidemiologic follow-up study","volume":"139","author":"Liao","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0955-2863(00)00142-X","article-title":"Misconceptions in the debate on the iron hypothesis","volume":"12","author":"Sullivan","year":"2001","journal-title":"J Nutr Biochem"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0100","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1523-1755.2001.059003883.x","article-title":"T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis","volume":"59","author":"van Riemsdijk","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0105","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","article-title":"Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes","volume":"154","author":"Descamps-Latscha","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.V113539","article-title":"Vitamine E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis","volume":"11","author":"Roob","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0115","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1172\/JCI0215093","article-title":"T helper subset development: Roles of instruction, selection, and transcription","volume":"109","author":"Farrar","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol Today"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1084\/jem.180.3.969","article-title":"Iron regulates nitric oxide synthase activity by controlling nuclear transcription","volume":"180","author":"Weiss","year":"1994","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0130","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1182\/blood.V91.7.2565","article-title":"Response of monocyte iron regulatory protein activity to inflammation: Abnormal behavior in genetic hemochromatosis","volume":"91","author":"Recalcati","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0135","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/516481","article-title":"Iron overload alters innate and T helper cell responses to Candida albicans in mice","volume":"175","author":"Mencacci","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4269\/ajtmh.1996.54.164","article-title":"Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy","volume":"54","author":"Thuma","year":"1996","journal-title":"Am J Trop Med Hyg"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0145","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/315052","article-title":"Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection","volume":"180","author":"Weiss","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0150","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1365-2362.2002.0320s1042.x","article-title":"Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients","volume":"32","author":"Esposito","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0155","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1046\/j.1365-2362.2002.0320s1036.x","article-title":"Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion","volume":"32","author":"Kooistra","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0160","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000169007","article-title":"Cardiovascular effects of increasing hemoglobin in chronic renal failure","volume":"16","author":"Mayer","year":"1996","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0165","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1046\/j.1365-2362.2002.0320s1070.x","article-title":"Iron an immunity\u2014A double edged sword","volume":"32","author":"Weiss","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0170","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1523-1755.1998.00084.x","article-title":"Role of cytokines in the response to erythropoietin in hemodialysis patients","volume":"54","author":"Goicoechea","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/16.suppl_7.36","article-title":"The role of inflammation in the anemia of end-stage renal disease","volume":"16","author":"Stenvinkel","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1046\/j.1523-1755.2003.00099.x_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abio.2002.5611","article-title":"A review of fluorescence methods for assessing labile iron in cells and biological fluids","volume":"304","author":"Esposito","year":"2002","journal-title":"Anal Biochem"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815493639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815493639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:01:42Z","timestamp":1682528502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815493639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["S0085253815493639"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00099.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}